Company Overview and News

0
Kavanaugh Eyed End to Affirmative Action, New Documents Indicate - Bloomberg

2018-07-21 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
FNMA

0
Regions Financial Corporation (RF) CEO John Turner on Q2 2018 Results - Earnings Call Transcript

2018-07-20 seekingalpha
Good morning, and welcome to the Regions Financial Corporation Quarterly Earnings Call. My name is Shelby, and I'll be your operator for today's call. I'd like to remind everyone that all participants all lines have been placed on listen only. At the end of the call, there will be a question-and-answer session. [Operator Instructions]
RF.PRB RF.PRA RF FNMA

0
Arbor Realty Trust Schedules Second Quarter 2018 Earnings Conference Call

2018-07-20 globenewswire
UNIONDALE, N.Y., July 20, 2018 (GLOBE NEWSWIRE) -- Arbor Realty Trust, Inc. (NYSE:ABR), today announced that it is scheduled to release second quarter 2018 financial results before the market opens on Friday, August 3, 2018. The Company will host a conference call to review the results at 10:00 a.m. Eastern Time on August 3, 2018.
ABR ABRN ABRN.CL ABR.PRB ABR.PRC FNMA ABR.PRA

16
Is Subprime Contained?

2018-07-19 seekingalpha
Jerome Powell will make his fourth required appearance of 2018 on Capitol Hill today. The Full Employment and Balanced Growth Act of 1978 required a great many things when it was passed forty years ago, among them a degree of forced monetary competence to be at least displayed publicly by the Federal Reserve. The charade of Congressional testimony is what remains on the books, a semiannual sojourn of kabuki theater playing in each house each time.
FMCCO FMCCP FMCCM FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FNMA FMCKK FMCKL FMCKI FMCKJ FMCC FMCCS FMCCT

16
Fannie Mae: The Boys Are Back In Town

2018-07-18 seekingalpha
The fifth circuit court of appeals ruled that FHFA is illegally structured, but that existing law could be amended and the net worth sweep stands.
FMCCO FMCCP FMCCM FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FNMA FMCKK FMCKL FMCKI FMCKJ FMCC FMCCS FMCCT

0
MGIC Investment Corporation (MTG) CEO Patrick Sinks on Q2 2018 Results - Earnings Call Transcript

2018-07-18 seekingalpha
Good day, ladies and gentlemen, and welcome to the MGIC Investment Corporation Second Quarter Earnings Call. At this time all participants are in a listen only mode. Later we will conduct a question and answer session and instruction will be given at that time. [Operator Instructions] As a reminder this call is being recorded.
MTG FNMA

18
Lessons for next US financial crisis from 3 key ex-officials

2018-07-18 nzherald.co.nz
WASHINGTON (AP) — Three officials who played vital roles in combating the 2008 financial crisis say they worry that the painful lessons from the banking system's near-collapse a decade ago may be forgotten.
FMCCO FMCCP FMCCM AVF FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP AIG FMCKM FMCKN FNMA FMCKK FMCKL FMCKI FMCKJ AIG.WS FMCC 8685 FMCCS FMCCT

18
Lessons for next US financial crisis from 3 key ex-officials

2018-07-18 nzherald.co.nz
WASHINGTON (AP) — Three officials who played vital roles in combating the 2008 financial crisis say they worry that the painful lessons from the banking system's near-collapse a decade ago may be forgotten.
FMCCO FMCCP FMCCM AVF FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP AIG FMCKM FMCKN FNMA FMCKK FMCKL FMCKI FMCKJ AIG.WS FMCC 8685 FMCCS FMCCT

0
Arbor Realty Trust, Inc. Announces Pricing of $130 million of 5.25% Convertible Senior Notes due 2021

2018-07-17 globenewswire
UNIONDALE, N.Y., July 17, 2018 (GLOBE NEWSWIRE) -- Arbor Realty Trust, Inc. (the “Company”) (NYSE:ABR) today announced the pricing of $130 million in aggregate principal amount of its 5.25% Convertible Senior Notes due 2021 (the “Notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The Company also granted the initial purchasers of the Notes a 30-day option to purchase up to an additional $19.
ABR ABRN ABRN.CL ABR.PRB ABR.PRC FNMA ABR.PRA

16
Fannie, Freddie shares dip after Fed's Powell remarks

2018-07-17 reuters
NEW YORK (Reuters) - Fannie Mae and Freddie Mac’s stock prices slipped on Tuesday after Federal Reserve Chairman Jerome Powell told a Senate panel that he thinks it’s important in the longer run the housing financial system be off the government’s balance sheet.
FMCCO FMCCP FMCCM FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FNMA FMCKK FMCKL FMCKI FMCKJ FMCC FMCCS FMCCT

0
Arbor Realty Trust, Inc. Announces Proposed Private Offering of Convertible Senior Notes due 2021

2018-07-17 globenewswire
UNIONDALE, N.Y., July 17, 2018 (GLOBE NEWSWIRE) -- Arbor Realty Trust, Inc. (the “Company”) (NYSE:ABR) today announced that it intends to offer, subject to market and other conditions, $110 million in aggregate principal amount of Convertible Senior Notes due 2021 (the “Notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act).
ABR ABRN ABRN.CL ABR.PRB ABR.PRC FNMA ABR.PRA

16
Can the mortgage market predict the presidency? - MarketWatch

2018-07-17 marketwatch
Few American homeowners — or wannabe homeowners — think about the ease of the financial mechanism that delivers their white picket fence or windowed high-rise with a city view. That is, until it’s taken away.
FMCCO FMCCP FMCCM FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FNMA FMCKK FMCKL FMCKI FMCKJ FMCC FMCCS FMCCT

0
FNMA / Fannie Mae 8-K (Current Report)

2018-07-16 sec.gov
Document UNITED STATES
FNMA

20
California’s Mortgage Fraud - WSJ

2018-07-16 wsj
Americans can be forgiven for forgetting what happened last week, let alone six years ago given today’s media blitz on all things Donald Trump. But it is worth remembering Obama-era abuses of power that, far from this week’s headlines, are having their day in court.
WFCNP WFC.PRL WFC.PRJ FNMA FMCKI WFC.PRT FMCKJ WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN WFC.PRY WFC.PRX WFC.PRW WFC.PRV WFC WFC.WS FMCCO FMCCP FMCCM FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK FMCKL FMCC FMCCS FMCCT

16
After Storm, Foreclosures in Puerto Rico Stopped. They’re Starting Again. - The New York Times

2018-07-16 nytimes
The foreclosure machine that ground to a halt in Puerto Rico after the devastation caused by Hurricane Maria in September is slowly cranking up again. Island residents who fell behind on their payments are facing creditors ranging from Wall Street to the federal government.
FMCCO FMCCP FMCCM FMCCN FMCCI FMCCJ FMCCG FMCKO NYTAB FMCKP FMCKM BKI FMCKN FNMA FMCKK FMCKL FMCKI FMCKJ FMCC FMCCS FMCCT

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 313586109